Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05579093 · ClinicalTrials.gov registry record
Clinical Investigation of an Eye-Tracking Device as a Predictor of Delirium in the Recovery Room After Surgery With General Anesthesia
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 325
- Enrollment target
NCT05579093 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 325 participants.
The verdict
NCT05579093 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 325 participants
- Enrollment target
Study Summary
Neurotrack™ is an FDA-approved device for measuring and tracking cognitive decline, as may occur with age-related cognitive decline and Alzheimer's disease. The device uses a webcam (World Wide Web enabled camera) to assess eye-tracking as the subject views black-and-white images on the computer screen. The test takes less than 5 minutes to complete. This study will examine the feasibility and utility of pre-operative assessment of cognition using Neurotrack™ technology. The predictive value of Neurotrack™ will be compared to our previous work using pupillometry. The primary outcome is a measure of delirium in the recovery room and secondary outcomes include total length of stay, intensive care unit (ICU) length of stay, and readmissions within 30 days of surgery.
Interventions
- COMBINATION_PRODUCT Cognitive test + Pupillary measure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05579093
The ClinicalTrials.gov registry entry for NCT05579093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive test + Pupillary measure is the first listed.
NCT05579093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05579093 about?
NCT05579093 is a clinical study titled "Clinical Investigation of an Eye-Tracking Device as a Predictor of Delirium in the Recovery Room After Surgery With General Anesthesia". Neurotrack™ is an FDA-approved device for measuring and tracking cognitive decline, as may occur with age-related cognitive decline and Alzheimer's disease. The device uses a webcam (World Wide Web enabled camera) to assess eye-tracking as the subject views black-and-white images on the computer scr...
What is the current status of trial NCT05579093?
This trial is currently completed. The enrollment target is 325 participants. The study started on 2019-10-01. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT05579093?
The interventions under investigation include: Cognitive test + Pupillary measure (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05579093?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.